Introduction
Thyroid nodules are frequently discovered in clinical practice, either during physical examination or incidentally during imaging procedures. In the general population, up to 50%-60% of healthy individuals have thyroid nodules (1) . The clinical significance of the evaluation of the thyroid nodule is mainly related to the need for exclusion of thyroid cancer, which accounts for 4%-6.5% of thyroid nodule cases and is usually independent of the nodule size (2, 3) . Fine-needle aspiration (FNA) is considered the most accurate method for distinguishing benign thyroid nodules from malignant ones (4). It is not appropriate to evaluate all thyroid nodules with FNA because of the high prevalence of such nodules.
Thyroid ultrasonography (US) is a valuable imaging method widely used for the evaluation of thyroid nodules. Although it is an inexpensive and noninvasive procedure, it provides important information about the nodules, such as the dimensions and parenchymal changes and structure. Thyroid US features that have been found to be independent risk factors for malignancy include irregular margins, incomplete halo, hypoechogenicity, microcalcifications, taller-than-wide shape, and central vascularity (5) . Nevertheless, the specificity, sensitivity, positive predictive value (PPV), and negative predictive value (NPV) of US is extremely variable across studies; none of the abovementioned features have both high specificity and high sensitivity (6, 7) .
Harder nodules generally tend to be malignant. However, conventional US does not provide information about the hardness of a nodule; therefore, elastography, which is a noninvasive method to obtain information about tissue stiffness, has been developed. Elastography scores (ESs) and strain indexes (SIs) of malignant nodules are higher than those of benign thyroid nodules (8, 9) . It has been reported that elastography is useful for the investigation of malignancy and may reduce the number of unnecessary FNAs (10) . ES and SI have been used to differentiate benign and malignant thyroid nodules in previous studies (11, 12) . However, their diagnostic value for thyroid micronodules has been assessed in only a few reports (13, 14) . Therefore, we aimed to investigate the diagnostic value of ES and SI for identifying the characteristics of thyroid micronodules.
Materials and methods
This prospective study was conducted between January 2016 and March 2017 in our hospital at the Department of Endocrinology and Metabolism outpatient clinic. The patients who had nodules with diameter of ≤10 mm determined on thyroid US at our hospital were enrolled in the study. There were 26 males and 198 females aged 21-74 years. Thyroid fine-needle aspiration biopsy (FNAB) were performed for all patients to investigate the diagnostic values of ES and SI. They were operated on if their cytology results confirmed or suspected malignancy according to the Bethesda system (BS) (15) . The study protocol was approved by the ethics committee of our hospital, and written informed consent was obtained from all the participants.
Thyroid US and elastography were performed using high-resolution B-mode gray-scale US, power Doppler US, and real-time US elastography (Preirus HV with 13-MHz linear transducer). Only one operator performed all the measurements. The classical gray-scale features of the nodules were evaluated. Color flow Doppler pattern was classified as type 1 in the absence of blood flow, type 2 in the presence of perinodular blood flow, and type 3 in the presence of a marked intranodular blood flow (16) . ES measurements were classified using the Itoh elasticity score scale (17) .
Thyroid-stimulating hormone (TSH) and free T4 (fT4) levels were measured using a chemiluminescent microparticle immunoassay (Abbott, Architect i2000, Abbott Laboratories Diagnostics Division, USA). The lower and upper limits were as follows: fT4: 0.58-1.60 ng/dL; TSH: 0.38-5.33 µIU/mL All the patients were euthyroid, and serum calcitonin was undetectable.
Statistical analysis
Statistical analysis was performed using SPSS 17 (SPSS Inc., Chicago, IL, USA). All the measurement data were reported as the mean ± standard deviation, and their differences were evaluated with the independent sample t-test. Sensitivity, specificity, PPV, and NPV were calculated from the cross tables. The associations between the categorical variables and malignancy, ES, or SI were evaluated using the Pearson chi-square test or Spearman rank test. Receiver operating characteristic (ROC) curves were analyzed, and the diagnostic performance of different variables was expressed as the area under the curve (AUC). P < 0.05 was considered statistically significant.
Results
The study included 198 (88.4%) females and 26 (11.6%) males with solitary thyroid nodules sized ≤10 mm in diameter on US. The mean age of the patients was 46.5 ± 12.2 years. Each patient had only one nodule, and 117 (52.2%) nodules were on the right, 92 (41.1%) on the left, and 15 (6.7%) in the isthmus. FNAB results of our study showed that 44 (19.6%) nodules were malignant, 19 (8.5%) were suspicious for malignancy, 43 (19.2%) had atypia of undetermined significance (AUS), 108 (48.2%) were benign, and 10 (4.5%) had nondiagnostic (ND) cytology.
ES was 1 in 17 cases and 2 in 63, all of which were nonmalignant; 3 in 74 cases, four of which were suspected of malignancy and nine of which were confirmed to be malignant; 4 in 60 cases, 14 of which were suspected of malignancy and 26 of which were confirmed to be malignant; and 5 in 10 cases, one of which was suspected of malignancy and nine of which were confirmed to be malignant ( Table 1 ). The patients whose FNAB results confirmed or suspected malignancy underwent surgery. According to the histopathological results, all of them were diagnosed with papillary thyroid microcarcinoma.
Of the 63 nodules that were histopathologically diagnosed as papillary microcarcinoma, 35 (55.6%) were hypoechoic, 34 had (54%) microcalcification, 35 had (55.6%) irregular margin, and only one had halo (1.6%). Doppler US showed that 10 of the 63 malignant nodules (15.9%) had type 3 vascularization pattern; there was no significant difference in the vascularity pattern between benign and malignant micronodules (P > 0.05). However, irregular margin, absence of peripheral halo, hypoechogenicity, and microcalcification were significantly different between the two groups (P < 0.001). There were no significant differences in the TSH levels between benign and malignant micronodules (1.8 ± 1.3 and 2.2 ± 1.2, respectively; P = 0.058) There were significant differences between the mean ES (2.3 ± 0.7 and 3.9 ± 0.6, respectively; P < 0.001) and SI (1.8 ± 0.9 and 4.8 ± 1.5, respectively; P < 0.001) for benign and malignant micronodules. We found that 52 micronodules had ES of >3, of which 50 (96.1%) were malignant. When we used ES to diagnose malignancy of thyroid micronodules, the AUC of the ROC curve was 0.888 (95% confidence interval: 0.826-0.950; P < 0.001; Table 2 ). ES represented malignancy; sensitivity, specificity, PPV, and NPV were 79.4%, 98.1%, 96.1%, and 89.1%, respectively ( Table 2) .
The optimal SI cutoff value that could differentiate between benign and malignant micronodules was 3.06, with 98% sensitivity and 91% specificity (AUC: 0.970; 95% confidence interval: 0.948-0.992; P < 0.001; Figure; Table 3 ).
Discussion
Thyroid nodules are commonly encountered in the general population; in recent years, the frequency of occurrence of thyroid nodules has increased (18) . This increased incidence is attributed to better diagnostic accuracy and screening. Thyroid micronodules generally receive clinical attention only after being incidentally detected by the physician. The exclusion of thyroid cancer during diagnosis is the main point in the investigation of these micronodules. In recent years, thyroid cancer incidence has substantially increased, particularly that of papillary thyroid cancer (19) , which can be attributed to papillary microcarcinomas sized <1 cm (20) .
Shrestha et al. grouped the nodules according to the size of the maximum diameter as follows: group A, 0.5-0.9 cm; group B, 1.0-3.9 cm, and group C, ≥4 cm (21). The subcentimeter nodules had the highest malignancy rate. Cavallo et al. also investigated the association between nodule size and malignancy and reported that malignancy risk was inversely correlated with nodule size because smaller nodules had higher malignancy rates (22) .
In our study, we evaluated 224 micronodules with FNAB, of which 108 were benign, 19 were suspected of malignancy, and 44 were malignant. The patients whose FNAB results confirmed or suspected malignancy underwent surgery. According to histopathological results, all these patients had papillary thyroid microcarcinoma. When benign, suspected malignant, and malignant nodules were evaluated based on FNAB (171 micronodules), the prevalence of malignancy in micronodules was 36.8%, which was higher than rates in other studies (21, 22) . Of the 224 micronodules evaluated using FNAB, 43 (19.2%) had AUS and 10 (4.5 %) had ND cytology. Moon et al., who investigated 1440 nodules sized 0.2-1.0 cm in diameter using FNAB, found that 17.8% were insufficient and concluded that the nodule size was inversely proportional to insufficiency rates (23) .
In 2008, Mazzaferri and Sipos recommended that FNAB should not be used for evaluating nodules of <0.5 cm in diameter because of the high rate of inadequate specimens (24) . On the other hand, the American Association of Clinical Endocrinologists recommended biopsy for nodules of ≤1 cm diameter and with suspicious US features (10) . However, the specificity, sensitivity, PPV, and NPV for these criteria considerably differ across studies. None of the US features have both high specificity and high sensitivity (6, 7) .
Elastography might be an additional tool for the diagnosis of thyroid carcinoma in micronodules in the general population. In the present study, we investigated the diagnostic performance of elastography for detecting malignant thyroid micronodules. We showed that ES and SI were significantly higher for malignant thyroid micronodules than for benign ones. Furthermore, the AUC of SI evaluation was greater than that of ES evaluation (0.970 vs. 0.888, respectively); therefore, we concluded that SI better reflects malignancy compared with ES in thyroid micronodules. Wang et al. reported 90.6% sensitivity and 89.4% specificity for ES of 4-5 in determining malignancy for nodules of <1 cm diameter (14) . Hong et al. in their malignancy study evaluated thyroid nodules sized <1 cm and reported 90% sensitivity, 82% specificity, 79% PPV, and 91% NPV for ES of ≥4 (25) . In our study, ES ≥4 represented malignancy, with sensitivity, specificity, PPV, and NPV of 79.4%, 98.1%, 96.1%, and 89.1%, respectively.
The results of the present study suggested that both ES and SI evaluations are valuable methods. Although Unluturk et al. reported that elastography is not a helpful method for predicting malignancy (26) , our study confirmed the usefulness of ES and SI in detecting malignant thyroid micronodules with high sensitivity and specificity. The optimal cutoff point for SI in diagnosing malignancy was 3.06 in our study. The limitation of our study was the lack of histopathological diagnosis of all nodules. Furthermore, we did not repeat FNAB in patients with AUS and ND cytology because that they did not return for follow-up.
In conclusion, the incidence of thyroid micronodules has been increasing in the general population, and the prevalence of malignancy is higher in such nodules. Previous studies have only recommended FNA of these nodules when US features are suspicious for malignancy; however, the results lack sensitivity and specificity. ES and SI are more useful measurements for diagnosing malignancy in thyroid micronodules. 
Figure.
Receiver operating characteristic (ROC) curve of strain index for distinguishing malignant micronodules from benign ones (AUC = 0.970; 95% CI: 0.948-0.992).
